Trial Profile
Double-Blind, Double-Dummy, Randomised, Multicentre, 12-Months, Comparative Study of the Efficacy and Tolerability of Once Daily 3.0 g Mesalazine Granules vs. Once Daily 1.5 g Mesalazine Granules vs. Three Times Daily 0.5 g Mesalazine Granules for Maintenance of Remission in Patients With Ulcerative Colitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Feb 2017
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 13 Oct 2009 New trial record.